Login / Signup

Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial.

Iain B McInnesGianfranco FerraccioliMaria Antonietta D'AgostinoManuela Le BarsSubhashis BanerjeeHarris A AhmadYedid ElbezPhillip J Mease
Published in: RMD open (2019)
NCT01860976.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • rheumatoid arthritis
  • phase ii
  • double blind
  • placebo controlled
  • rheumatoid arthritis patients
  • randomized controlled trial
  • study protocol